# Can circulating microRNAs predict colorectal cancer? Results from a nested case–control study of pre-diagnostic serum samples from two prospective biobanks

**Authors:** Eva Hofsli, Pål Sætrom, Eivind Ness-Jensen, Helja-Marja Surcel, Robin Mjelle

PMC · DOI: 10.1186/s12885-025-13854-1 · BMC Cancer · 2025-03-13

## TL;DR

This study explores whether specific microRNAs in blood can predict future colorectal cancer, focusing on metastatic cases.

## Contribution

The study identifies specific miRNAs associated with future metastatic colorectal cancer in pre-diagnostic serum samples.

## Key findings

- miR-223-3p and miR-21-5p were significantly up-regulated in future metastatic cases in the FMC cohort.
- Consistent up-regulation of miR-584-5p, miR-30c-5p, miR-146a-5p, miR-10a-5p, and miR-1306-5p was observed across cohorts in future metastatic cases.
- The study highlights the potential of serum miRNAs as non-invasive biomarkers for metastatic colorectal cancer.

## Abstract

This study aimed to investigate the potential of circulating small RNAs (sRNAs) as predictive biomarkers for future colorectal cancer (CRC). The study analyzed serum samples from pre-diagnostic CRC patients in two prospective biobanks.

Serum samples from 142 pre-diagnostic CRC patients, from the Finnish Maternity Cohort (FMC) and The HUNT Study (HUNT2), were subjected to small RNA sequencing. The study compared sRNA expression in CRC cases with controls, considering diverse sRNA classes.

Analysis revealed diverse miRNA expression patterns with notable variations in future metastatic cases. Specifically, miR-223-3p and miR-21-5p showed significant up-regulation in future metastatic cases in the FMC cohort. Consistent changes were observed across cohorts, with miR-584-5p, miR-30c-5p, miR-146a-5p, miR-10a-5p, and miR-1306-5p showing up-regulation in future metastatic cases.

The study identified potential serum miRNA biomarkers associated with metastatic CRC, though statistical significance varied. These findings contribute to the understanding of miRNA profiles in pre-diagnostic CRC patients, emphasizing the need for further exploration of non-invasive biomarkers in large prospective studies.

The online version contains supplementary material available at 10.1186/s12885-025-13854-1.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** MIR215 (microRNA 215) [NCBI Gene 406997] {aka MIRN215, miRNA215, mir-215}
- **Diseases:** CRC (MESH:D015179)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11905635/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11905635/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11905635/full.md

---
Source: https://tomesphere.com/paper/PMC11905635